Browse > Article
http://dx.doi.org/10.5012/bkcs.2002.23.11.1623

Synthesis of Tetracyclic Pyrido[2,3-b]azepine Derivatives as Analogues of Mirtazapine via N-Acyliminium Ion Cyclization  

Lee, Jae-Yeol
Bang, Sung-Hun
Lee, Sook-Ja
Song, Yun-Seon
Jin, Chang-Bae
Park, Ho-Koon
Lee, Yong-Sup
Publication Information
Abstract
Tetracyclic pyrido[2,3-b]azepine derivatives 4a-d and 4f as analogues of mirtazapine were synthesized via N-acyliminium ion cyclization by using aromatic rings such as benzene and thiophene ring as a ${\pi}-nucleophile$, and evaluated for the binding affinity for ${\alpha}2-adrenoceptor$. Among tested compounds, 2,3,9,13b-tetrahydro-1H-benzo[f]pyrrolo[2,1-a]pyrido[2,3-c]azepine (4a) was the most potent (Ki = 0.26 ${\mu}M)$ but showed about 3-fold less binding affinity than mirtazapine (Ki = 0.08 ${\mu}M)$ for a2-adrenoceptor.
Keywords
Pyrido[2,3-b]azepine; N-Acyliminium ion cyclization; ${\alpha}_2$-Adrenoceptor; Mirtazapine;
Citations & Related Records

Times Cited By Web Of Science : 3  (Related Records In Web of Science)
Times Cited By SCOPUS : 4
연도 인용수 순위
1 Briel, D. Pharmazie. 1990, 45, 895-899.
2 Kim, J. H.; Lee, Y. S.; Park, H.; Kim, C. S. Tetrahedron 1998, 54, 7395-7400.   DOI   ScienceOn
3 Dijkink, J.; Speckamp, W. N. Tetrahedron 1978, 34, 173-178.   DOI   ScienceOn
4 Kang, J.; Lee, J. W.; Kim, J. I.; Pyun, C. Tetrahedron Lett. 1995, 36, 4265-4268.   DOI   ScienceOn
5 Tanis, S. P.; Deaton, M. V.; Dixon, L. A.; McMills, M. C.; Raggon, J. W.; Collins, M. A. J. Org. Chem. 1998, 63, 6914-6928.   DOI   ScienceOn
6 Lee, Y. S.; Min, B. J.; Park, Y. K.; Lee, J. Y.; Lee, S. J.; Park, H. Tetrahedron Lett. 1999, 40, 5569-5572.   DOI   ScienceOn
7 Nickolson, V. J.; Wieringa, J. H. J. Pharm. Pharmacol. 1981, 33, 760-766.   DOI
8 Pinder, R. M.; Van Delft, A. M. L. Br. J. Clin. Pharmacol. 1983, 15, 269S-276S.   DOI   ScienceOn
9 Kang, J.; Lee, C. W.; Lim, G. J.; Cho, B. T. Tetrahedron: Asymmetry 1999, 10, 657-660.   DOI   ScienceOn
10 Reinhard, R.; Glaser, M.; Neumann, R.; Maas, G. J. Org. Chem. 1997, 62, 7744-7751.   DOI   ScienceOn
11 Haddjeri, N.; Blier, P.; De Montigny, C. J. Pharmacol. Exp. Ther. 1996, 277, 861-871.
12 Draper, R. W.; Hou, D.; Iyer, R.; Lee, G. M.; Liang, J. T.; Mas, J. L.; Tormos, W.; Vater, E. J.; Gunter, F.; Mergelsberg, I.; Scherer, D. Org. Process Res. Dev. 1998, 2, 175-185.   DOI   ScienceOn
13 Lee, J. Y.; Baek, N. J.; Lee, S. J.; Park, H.; Lee, Y. S. Heterocycles 2001, 55, 1519-1526.   DOI   ScienceOn
14 McKenna, M. T.; Proctor, G. R.; Young, L. C.; Harvey, A. L. J. Med. Chem. 1997, 40, 3516-3523.   DOI   ScienceOn
15 Parikh, J. R.; Doering, W. E. J. Am. Chem. Soc. 1967, 89, 5505-5507.   DOI
16 De Boer, T.; Nefkens, F.; Van Helvoirt, A. Eur. J. Pharmacol. 1994, 253, R5-R6.   DOI   ScienceOn
17 Berger, J. G.; Chang, W. K.; Clader, J. W.; Hou, D.; Chipken, R. E.; McPhail, A. T. J. Med. Chem. 1989, 32, 1913-1921.   DOI
18 Wood, M. D.; Thomas, D. R. Watkins, C. J.; Newberry, N. R. J. Pharm. Pharmacol. 1993, 45, 711-714.   DOI
19 Chung, S.-H.; Yook, J.; Min, B. J.; Lee, J. Y.; Lee, Y. S.; Jin, C. Arch. Pharm. Res. 2000, 23, 353-359.   DOI   ScienceOn
20 De Boer, T.; Nefkens, F.; Van Helvoirt, A.; Van Delft, A. M. L. J. Pharmacol. Exp. Ther. 1996, 277, 852-860.
21 Roeder, T.; Degen, J.; Gewecke, M. Eur. J. Pharmacol. 1998, 349, 171-177.   DOI   ScienceOn
22 Kametani, S.; Surgenor, A.; Fukumoto, K. J. Chem. Soc. Perkin Trans. 1 1981, 920-925.   DOI